OAM
CELG

Oppenheimer Asset Management’s Celgene Corp CELG Stock Holding History

Oppenheimer Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10
Closed -$1K – 1664
2019
Q3 		$1K Sell
10
-25
-71% -$2.38K ﹤0.01% 1599
2019
Q2 		$3K Sell
35
-275
-89% -$26.1K ﹤0.01% 1585
2019
Q1 		$29K Sell
310
-7,030
-96% -$615K ﹤0.01% 1426
2018
Q4 		$470K Sell
7,340
-2,218
-23% -$164K 0.01% 788
2018
Q3 		$856K Buy
9,558
+2,817
+42% +$249K 0.02% 657
2018
Q2 		$534K Buy
6,741
+480
+8% +$39.9K 0.01% 778
2018
Q1 		$559K Sell
6,261
-100,174
-94% -$9.62M 0.01% 760
2017
Q4 		$15.5M Hold
106,435
– – 0.41% 53
2017
Q3 		$15.5M Sell
106,435
-3,978
-4% -$542K 0.4% 54
2017
Q2 		$14.3M Sell
110,413
-12,428
-10% -$1.52M 0.4% 55
2017
Q1 		$15.3M Buy
+122,841
New +$14.7M 0.44% 47

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Oppenheimer Asset Management's CELG Position: Q4 2019 in Review

Oppenheimer Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10 shares — an estimated $1K sold.

Oppenheimer Asset Management first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $15.5M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oppenheimer Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oppenheimer Asset Management sold 10 Celgene Corp shares in Q4 2019, an estimated $1K.
  • Oppenheimer Asset Management first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Oppenheimer Asset Management's Celgene Corp position peaked at $15.5M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oppenheimer Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.